ArisInfra Solutions Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026, to BSE Limited and the National Stock Exchange of India Ltd, in compliance with Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was prepared by ICRA Limited, the appointed Monitoring Agency, and filed on May 08, 2026. The report confirms that the utilisation of issue proceeds is in line with the objects of the issue, with no material deviation observed.

Issue and Proceeds Overview

The company's Initial Public Offer had an opening date of June 18, 2025, and a closing date of June 20, 2025. ICRA monitored a total proceeds amount of INR 579.60 crore during Q4 FY2026, comprising Pre-IPO proceeds of INR 80.004 crore and IPO proceeds of INR 499.596 crore. The net proceeds as per the prospectus stood at INR 461.442 crore (excluding issue-related expenses), while the actual net proceeds were INR 476.115 crore. The revision in net proceeds is on account of actual offer-related expenditure being lower than estimated by INR 14.672 crore.

Utilisation of IPO Proceeds — Object-wise Progress

The following table details the object-wise utilisation of IPO proceeds as at the end of Q4 FY2026 (March 31, 2026):

The General Corporate Purpose (GCP) allocation was revised upward from INR 31.842 crore (as per the prospectus) to INR 46.514 crore, reflecting the reduction in offer-related expenses. ICRA noted that the revision of 46% in the GCP amount is on account of actual offer-related expenditure being lower than estimated by INR 14.672 crore, and the revised amount remains within the limit of 25% of Gross Proceeds.

Utilisation of Pre-IPO Proceeds

For the Pre-IPO placement of INR 80.004 crore, the entire amount was designated for general corporate purposes. As at the end of Q4 FY2026, INR 78.107 crore had been utilised cumulatively, with INR 15.685 crore deployed during the quarter, leaving an unutilised balance of INR 1.897 crore.

During Q4 FY2026, utilisation under Pre-IPO proceeds included management development deposits to Natureresidences Real Estate Development Private Limited of INR 3.00 crore and Natureresidences Realtors Private Limited of INR 10.00 crore, both refundable in nature, along with salary expenses of INR 0.621 crore, tax payment of INR 1.564 crore, and vendor payment of INR 0.500 crore.

GCP Utilisation Breakdown

The following tables provide a detailed breakdown of cumulative General Corporate Purpose utilisation under both Pre-IPO and IPO proceeds as reported by ICRA.

Pre-IPO Proceeds — GCP Utilisation

IPO Proceeds — GCP Utilisation

During Q4 FY2026, the company received a refund of INR 2.151 crore from an initial deposit of INR 20.00 crore placed with AVS Housing & Construction LLP in Q2 FY2025-26, and the same amount was utilised in Q4 FY2026 for payment towards management deposits to Natureresidences Real Estate Development Private Limited (INR 2.000 crore), rent and admin expenses (INR 0.019 crore), and vendor payment (INR 0.132 crore).

Deployment of Unutilised Proceeds

Unutilised Pre-IPO proceeds were deployed primarily in term deposits with IDBI Bank, with a balance also maintained in the Pre-IPO account. The total amount invested stood at INR 1.908 crore, generating earnings of INR 0.004 crore, with a market value of INR 1.912 crore as at March 31, 2026.

Unutilised IPO proceeds were deployed in a term deposit with Axis Bank and balances maintained across the GCP account, monitoring account, and Axis sub-account. The total amount invested was INR 3.223 crore, generating earnings of INR 0.026 crore, with a market value of INR 3.249 crore as at March 31, 2026.

Implementation Schedule and Compliance

All objects under both Pre-IPO and IPO proceeds are reported as on schedule as of March 31, 2026, with no delays recorded. Key compliance observations from the monitoring report include:

• No material deviation from the objects of the issue was identified.
• All utilisation is confirmed to be as per the disclosures in the offer document.
• Shareholder approval for material deviations is not applicable, as no material deviation was observed.
• The means of finance for disclosed objects has not changed.
• No major deviation was observed over earlier monitoring agency reports.
• All government and statutory approvals related to the objects have been obtained.
• No favorable or unfavorable events materially affecting the viability of the objects were reported.

The report was signed by Parul Goyal Narang, Vice President & Head – Process Excellence at ICRA Limited, and submitted to the stock exchanges by Bhavik Jayesh Khara, Whole-time Director and CFO of ArisInfra Solutions Limited.

Arisinfra Solutions Limited's Nomination and Remuneration Committee (NRC) convened on May 08, 2026, and approved the grant of employee stock options under its established employee stock option scheme. The meeting commenced at 12:00 p.m. (IST) and concluded at 12:30 p.m. (IST), with the resolution passed in accordance with applicable regulatory requirements.

ESOP Grant Details

The NRC approved the grant of 2,041 employee stock options amounting to Rs. 5,00,000/- under the 'Arisinfra Solutions Limited - Employee Stock Option Plan - 2024' (Arisinfra ESOP - 2024). Each stock option entitles the option holder to apply for one equity share of the company of Rs. 2/- each at the time of exercise. The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The following table summarises the key details of the grant as disclosed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015:

Pricing and Exercise Terms

The exercise price per option shall be determined by the Board of Directors or the NRC, as applicable, and shall not be less than the face value of the equity share of the company as on the date of grant of such options. The specific exercise price so determined shall be intimated to the option grantee through the Grant Letter at the time of grant. The time within which the options may be exercised and other significant terms shall be governed as per the Arisinfra ESOP - 2024 plan.

Regulatory Disclosure

The intimation has been made in accordance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The disclosure has also been uploaded on the company's website. The intimation was signed by Bhavik Jayesh Khara, Whole Time Director & CFO (DIN: 09095925), on behalf of Arisinfra Solutions Limited, from Mumbai.